Discovering new ways to understand cholesterol balance in the brain related to Alzheimer's disease
Ligand discovery for delineating cholesterol homeostasis in the brain
This study is looking at how cholesterol levels in the brain might influence Alzheimer's disease and is testing a new imaging technique to see a key enzyme that helps manage cholesterol, which could lead to better understanding and treatments for the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11010804 on NIH RePORTER |
What this research studies
This research focuses on Alzheimer's disease, a serious neurodegenerative condition, and investigates how cholesterol balance in the brain affects its progression. The study aims to develop a new imaging technique using positron emission tomography (PET) to visualize a specific enzyme, CYP46A1, that plays a crucial role in maintaining cholesterol levels in the brain. By creating a suitable ligand for this enzyme, researchers hope to better understand its function in Alzheimer's and assess the effectiveness of potential new therapies. This approach could provide insights that are currently difficult to obtain through traditional methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for Alzheimer's disease.
How similar studies have performed: While there have been studies on cholesterol's role in neurodegenerative diseases, the specific approach of imaging CYP46A1 in vivo is novel and has not been successfully demonstrated before.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Liang, Steven H — Emory University
- Study coordinator: Liang, Steven H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.